Treatment response to Janus kinase inhibitor in a child affected by Aicardi-Goutières syndrome.

Jessica Galli,Marco Cattalini, Erika Loi,Rosalba Monica Ferraro,Silvia Giliani,Simona Orcesi,Lorenzo Pinelli,Raffaele Badolato,Elisa Fazzi

Clinical case reports（2023）

引用 0|浏览23

暂无评分

摘要

We report the treatment response to baricitinib, a JAK-inhibitor, in a 4-year-old girl affected by Aicardi-Goutières syndrome (AGS2, mutation). Using quantitative measures, we detected a significant amelioration characterized by a complete recovery of cognitive, communicative, and relational skills after 8 and 16 months from the beginning of therapy.

查看译文

关键词

janus kinase inhibitor,syndrome,treatment

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要